MIRA INFORM REPORT

 

 

Report No. :

356048

Report Date :

21.12.2015

 

IDENTIFICATION DETAILS

 

Name :

VITABLEND NEDERLAND B.V.

 

 

Registered Office :

Frisaxstraat 1 8471ZW Wolvega

 

 

Country :

Netherlands

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

29.12.2000

 

 

Com. Reg. No.:

KvK-nummer: 01108877

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

  • Manufacture of basic pharmaceutical products.
  • Specialised wholesale of other raw and semi-finished materials for the manufacturing of food.

 

 

No. of Employee :

25

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Netherlands

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

NETHERLANDS ECONOMIC OVERVIEW

 

The Netherlands, the sixth-largest economy in the European Union, plays an important role as a European transportation hub, with a persistently high trade surplus, stable industrial relations, and moderate unemployment. Industry focuses on food processing, chemicals, petroleum refining, and electrical machinery. A highly mechanized agricultural sector employs only 2% of the labor force but provides large surpluses for food-processing and underpins the country’s status as the world’s second largest agricultural exporter. The Netherlands is part of the Eurozone, and as such, its monetary policy is controlled by the European Central Bank. The Dutch financial sector is highly concentrated, with four commercial banks possessing over 90% of banking assets. The sector suffered as a result of the global financial crisis and required billions of dollars of government support, but the European Banking Authority completed stringent reviews in 2014 and deemed Dutch banks to be well-capitalized. To address the 2009 and 2010 economic downturns, the government sought to stimulate the domestic economy by accelerating infrastructure programs, offering corporate tax breaks for employers to retain workers, and expanding export credits. The stimulus programs and bank bailouts, however, resulted in a government budget deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7% in 2008. The government of Prime Minister Mark RUTTE has since implemented significant austerity measures to improve public finances and has instituted broad structural reforms in key policy areas, including the labor market, the housing sector, the energy market, and the pension system. As a result, the government budget deficit at the end of 2014 dropped to 1.8% of GDP. Following a protracted recession during which unemployment doubled to 7.4% and household consumption contracted for nearly three consecutive years, the year 2014 saw fragile GDP growth of 0.8 percent and a rise in most economic indicators. Drivers of growth included increased exports and business investments, as well as newly invigorated household consumption.

 

Source : CIA

 

Summary

 

Company name                        Vitablend Nederland B.V.

Operative address                    Frisaxstraat 1

8471ZW Wolvega

Netherlands

 

Legal form                               Private Limited Company

Registration number                KvK-nummer: 01108877

VAT-number                             814886279

 

 

Year

 

2014

Mutation

2013

Mutation

2012

Fixed  assets

1.792.759

-4,34

1.874.187

9,63

1.709.579

Total  receivables

4.370.425

15,89

3.771.147

-19,49

4.684.139

Total  equity

5.119.303

-29,89

7.301.829

20,99

6.035.194

Short  term  liabilities

4.153.471

3,60

4.008.989

10,95

3.613.430

Net  result

817.474

-35,46

1.266.635

12,87

1.122.164

Working  capital

3.376.040

-38,36

5.477.138

22,60

4.467.499

Quick  ratio

1,17

-31,18

1,70

30,77

1,30

 

 

 

 

Contact information

 

Company name

Vitablend Nederland B.V.

Trade names

Vitablend Nederland B.V.

 

 

Operative address

Frisaxstraat 1

 

8471ZW Wolvega

 

Netherlands

 

 

Correspondence address

Postbus 220

 

8470AE Wolvega

 

Netherlands

 

 

Telephone number

0561691888

Fax number

0561614501

 

 

Email address

info@vitablend.nl

Website

www.vitablend.nl

 

 

Registration

 

Registration number

KvK-nummer: 01108877

Branch number

000016647351

VAT-number

814886279

 

 

Status

Active

First registration company register

2005-05-31

Memorandum

2005-05-30

Establishment date

2000-12-29

 

 

Legal form

Private Limited Company

Legal person since

2005-05-30

 

 

Issued placed capital

EUR 18.000

Paid up share capital

EUR 18.000

 

 

Activities

 

SBI

2110: Manufacture of basic pharmaceutical products

 

46389: Specialised wholesale of other raw and semi-finished materials for the manufacturing of food

 

 

Exporter

No

Importer

No

 

 

Goal

De in- en verkoop van grondstoffen en het produceren van mengsels voor de

 

farmaceutische- en levensmiddelenindustrie.

 

 


Relations

 

Shareholders                          Vitablend Holding B.V.

Frisaxstraat 1C

8471ZW WOLVEGA

Netherlands

Registration number: 01091025

Percentage: 100%

Companies on same address   Barentz Ingredients B.V.

Registration number: 34171313

Vsquare B.V.

Registration number: 50018094

 

 

Bank details

 

Accounts                                  ABN Amro Bank NV

Account number: NL75ABNA0581354451

BIC: ABNANL2A

 

 

Management

 

Active management                  Vitablend Holding B.V.

Frisaxstraat 1C

8471ZW WOLVEGA

Netherlands

Registration number: 01091025

Competence: Fully authorized

Function: Manager

Starting date: 2005-05-30

Barentz International B.V.

Saturnusstraat 15

2132HB Hoofddorp

Netherlands

Registration number: 34072351

Competence: Fully authorized

Function: General Director

Starting date: 2012-07-01

E.H.W. Engbersen Erik Herman Willibrordus

Netherlands

Competence: Fully authorized

Function: Proxy

Starting date: 2015-11-18

Date of birth: 1963-11-07, Almelo, NL

Involved with the following companies:

MDB Twello B.V.

Oude Rijksstraatweg 36

7391ME TWELLO

Netherlands

Registration number: 08042245

Function: Proxy

C. Schepers Cornelis

Netherlands

Competence: Fully authorized

Function: Proxy

Starting date: 2013-07-15

 

Date of birth: 1969-05-30, Hardenberg, NL

Involved with the following companies:

MDB Twello B.V.

Oude Rijksstraatweg 36

7391ME TWELLO

Netherlands

Registration number: 08042245

Function: Proxy

L. van der Wal Linda

Netherlands

Competence: Limited authorization

Function: Proxy

Starting date: 2015-11-18

Date of birth: 1981-03-13, Heerenveen, NL

D. Weistra Dirk-Pieter

Netherlands

Competence: Limited authorization

Function: Proxy

Starting date: 2015-11-18

Date of birth: 1989-02-05, Harlingen, NL

 

 

Employees

 

Total according to the Chamber of Commerce

25

 

 

Year

 

2015

2014

2013

2012

2011

Total

25

65

63

56

45

 

 

 

 

Payments

 

Description                  Payments are made regularly no complaints are known

 

 

Key figures

 

Year

 

2014

2013

2012

2011

2010

Quick  ratio

1,17

1,70

1,30

1,06

0,94

Current  ratio

1,81

2,37

2,24

1,71

1,53

 

 

Year

 

2014

2013

2012

2011

2010

Working  capital/  balance  total

0,36

0,48

0,46

0,33

0,25

Equity  /  balance  total

0,55

0,64

0,62

0,49

0,44

Equity  /  Fixed  assets

2,86

3,90

3,53

2,53

1,65

Equity  /  liabilities

1,22

1,80

1,61

0,94

0,79

Balance  total  /  liabilities

2,22

2,80

2,61

1,94

1,79

Working  capital

3.376.040

5.477.138

4.467.499

3.381.524

2.016.195

Equity

5.119.303

7.301.829

6.035.194

4.913.030

3.525.172

Mutation  equity

-29,89

20,99

22,84

39,37

65,15

Mutation  short  term  liabilities

3,60

10,95

-24,63

25,92

2,16

Return  on  total  assets  (ROA)

11,70

14,92

15,11

18,32

23,49

Return  on  equity  (ROE)

21,31

23,21

24,51

37,72

53,03

Gross  margin

8.712.311

8.512.818

7.120.355

7.072.434

6.553.299

Operating  result

1.048.306

1.750.431

1.640.331

1.869.373

1.927.222

Net  result  after  taxes

817.474

1.266.635

1.122.164

1.387.858

1.390.668

Cashflow

1.528.851

1.912.262

1.803.132

2.038.495

1.995.512

EBIT

1.048.306

1.750.431

1.640.331

1.869.373

1.927.222

EBITDA

1.759.683

2.396.058

2.321.299

2.520.010

2.532.066

 

 

Summary         The 2014 financial result structure is a postive working captial of 3.376.040 euro, which is in

agreement with 36 % of the total assets of the company.

The working capital has diminished with -38.36 % compared to previous year. The ratio, with

respect to the total assets of the company has however, declined.

The deterioration between 2013 and 2014 has mainly been caused by an increase of the

current liabilities.

The current ratio of the company in 2014 was 1.81. A company with a current ratio between

1.5 and 3.0 generally indicates good short-term financial strength.

The quick ratio in 2014 of the company was 1.17. A company with a Quick Ratio of more than

1 can currently pay back its current liabilities.

The 2013 financial result structure is a postive working captial of 5.477.138 euro, which is in

agreement with 48 % of the total assets of the company.

The working capital has increased with 22.6 % compared to previous year. The ratio, with

respect to the total assets of the company has however, increased.

The improvement between 2012 and 2013 has mainly been caused by an increase of the

current assets.

The current ratio of the company in 2013 was 2.37. A company with a current ratio between

1.5 and 3.0 generally indicates good short-term financial strength.

The quick ratio in 2013 of the company was 1.7. A company with a Quick Ratio of more than

1 can currently pay back its current liabilities.

 

 

 

 

Financial statement

 

Last annual account                 2014

Remark annual account            The company is obliged to file its financial statements.

Type of annual account            Corporate

Annual account                        Vitablend Nederland B.V.

Frisaxstraat 1

8471ZW Wolvega

Netherlands

Registration number: 01108877

 

 

Balance sheet

 

Year

 

2014

2013

2012

2011

2010

End  date

2014-12-31

2013-12-31

2012-12-31

2011-12-31

2010-12-31

Tangible  fixed  assets

1.792.759

1.874.187

1.709.579

1.938.380

2.135.811

Fixed  assets

1.792.759

1.874.187

1.709.579

1.938.380

2.135.811

Total  stock

2.664.184

2.662.450

3.396.790

3.103.321

2.262.252

Accounts  receivable

2.722.264

2.893.578

3.620.503

3.588.061

2.210.601

Other  receivables

1.648.161

877.569

1.063.636

619.393

508.732

Total  receivables

4.370.425

3.771.147

4.684.139

4.207.454

2.719.333

Liquid  funds

494.902

3.052.530

 

865.148

842.162

Current  assets

7.529.511

9.486.127

8.080.929

8.175.923

5.823.747

Total  assets

9.322.270

11.360.314

9.790.508

10.114.303

7.959.558

Issued  capital

18.000

18.000

18.000

18.000

18.000

Share  premium  reserve

389.419

389.419

389.419

389.419

389.419

Other  reserves

4.711.884

6.894.410

5.627.775

4.505.611

3.117.753

Total  reserves

5.101.303

7.283.829

6.017.194

4.895.030

3.507.172

Total  equity

5.119.303

7.301.829

6.035.194

4.913.030

3.525.172

Long  term  interest  yielding  debt

49.496

49.496

141.884

406.874

626.834

Long  term  liabilities

49.496

49.496

141.884

406.874

626.834

Accounts  payable

2.107.236

2.414.923

2.364.199

2.565.882

2.491.594

Other  short  term  liabilities

2.046.235

1.594.066

1.249.231

2.228.517

1.315.958

 

 

Summary         The total assets of the company decreased with -17.94 % between 2013 and 2014.

This total assets decrease has been reflected in a reduction of non current assets of -4.34 %.

The asset reduction results in an equity decrease of -29.89 %. Despite the decrease, the

indebtness increased with 3.56 %.

In 2014 the assets of the company were 19.23 % composed of fixed assets and 80.77 % by

current assets. The assets are being financed by an equity of 54.91 %, and total debt of

45.09 %.

The total assets of the company increased with 16.03 % between 2012 and 2013.

The fixed asset growth of 9.63 % is lower than the total asset growth.

The asset growth has mainly been financed by a Net Worth increase of 20.99 %. Debt,

however, grew with 8.07 %.

In 2013 the assets of the company were 16.5 % composed of fixed assets and 83.5 % by

current assets. The assets are being financed by an equity of 64.27 %, and total debt of

35.73 %.

 

 

 

 

 

 

Profit and loss

 

Year

 

2014

2013

2012

2011

2010

Gross  margin

8.712.311

8.512.818

7.120.355

7.072.434

6.553.299

Wages  and  salaries

3.891.100

3.218.597

2.613.526

2.445.673

2.351.778

Amorization  and  depreciation

711.377

645.627

680.968

650.637

604.844

 

 

Year

 

2014

2013

2012

2011

2010

other  operating  costs

3.061.528

2.898.163

2.185.530

2.106.751

1.669.455

Operating  expenses

7.664.005

6.762.387

5.480.024

5.203.061

4.626.077

Operating  result

1.048.306

1.750.431

1.640.331

1.869.373

1.927.222

Financial  income

42.666

 

 

 

 

Financial  expenses

 

55.703

160.949

16.262

57.829

Financial  result

42.666

-55.703

-160.949

-16.262

-57.829

Result  on  ordinary  operations  before  taxes

1.090.972

1.694.728

1.479.382

1.853.111

1.869.393

Taxation  on  the  result  of  ordinary  activities

273.498

428.093

357.218

465.253

478.725

Result  of  ordinary  activities  after  taxes

817.474

1.266.635

1.122.164

1.387.858

1.390.668

Net  result

817.474

1.266.635

1.122.164

1.387.858

1.390.668

 

 

Summary         The gross profit of the company grew with 2.34 % between 2013 and 2014.

The operating result of the company declined with -40.11 % between 2013 and 2014. This

evolution implies an decrease of the company's economic profitability.

The result of these changes is a reduction of the company's Economic Profitability of -21.58

% of the analysed period, being equal to 11.7 in the year 2014.

The Net Result of the company decreased by -35.46 % between 2013 and 2014.

The company's Financial Profitability has been positively affected by the financial activities in

comparison to the EBITs behaviour. The result of these variations is a profitability increase of

-8.19 % of the analysed period, being 21.31 in the year 2014.

The company's financial profitability has been positively affected by its financial structure.

The gross profit of the company grew with 19.56 % between 2012 and 2013.

The operating result of the company grew with 6.71 % between 2012 and 2013. This

evolution implies an increase of the company's economic profitability.

The result of these changes is a reduction of the company's Economic Profitability of -1.26 %

of the analysed period, being equal to 14.92 in the year 2013.

The Net Result of the company increased by 12.87 % between 2012 and 2013.

The company's Financial Profitability has been positively affected by the financial activities in

comparison to the EBITs behaviour. The result of these variations is a profitability increase of

-5.3 % of the analysed period, being 23.21 in the year 2013.

The company's financial profitability has been positively affected by its financial structure.

 

 

 

 

Analysis

 

Branch (SBI)                 Manufacture of basic pharmaceutical products and pharmaceutical preparations (SBI code21)

Region                         Friesland

Summary                     In the Netherlands 351 of the companies are registered with the SBI code 21

In the region Friesland 4 of the companies are registered with the SBI code 21

In the Netherlands 7 of the bankrupcties are published within this sector

The risk of this specific sector in the Netherlands is normal

The risk of this specific sector in the region Friesland is normal

 

 

Publications

 

Deposits                       04-11-2015: De jaarrekening over 2014 is gepubliceerd.

19-11-2014: De jaarrekening over 2013 is gepubliceerd.

20-09-2013: De jaarrekening over 2012 is gepubliceerd.

19-06-2012: De jaarrekening over 2011 is gepubliceerd.

27-07-2011: De jaarrekening over 2010 is gepubliceerd.

 

Functions                     02-12-2015: Per 18-11-2015 is gevolmachtigde Dirk-Pieter Weistra in functie getreden.

02-12-2015: Per 18-11-2015 is gevolmachtigde Erik Herman Willibrordus Engbersen in

functie getreden.

02-12-2015: Per 18-11-2015 is gevolmachtigde Linda van der Wal in functie getreden.

23-11-2015: Per 30-09-2015 is gevolmachtigde Anneke Corry Offeringa uit functie getreden.

23-11-2015: Per 01-10-2015 is gevolmachtigde Maarten Christiaan de Boer uit functie

getreden.

23-11-2015: Per 31-01-2015 is gevolmachtigde Marjan Fetje Jellesma-Eijgelaar uit functie getreden.

23-11-2015: Per 31-10-2015 is gevolmachtigde Fokje Kramer-de Boer uit functie getreden.

05-08-2013: Per 02-08-2013 is gevolmachtigde Hilke Berdina Cornelia Heezen uit functie

getreden.

05-08-2013: Per 02-08-2013 is gevolmachtigde Paula Kuijper-Schuit uit functie getreden.

05-08-2013: Per 15-07-2013 is gevolmachtigde Cornelis Schepers in functie getreden.

05-07-2012: Per 01-07-2012 is bestuurder 34072351 Barentz Europe B.V. in functie

getreden.

16-05-2012: Per 01-05-2012 is gevolmachtigde Jacobus Frederik Boers uit functie getreden.

 

 

Company structure

 

Relations                                                          3

 

Company                                                                                             Registration number

Vitablend Holding B.V. (WOLVEGA)                                                                 01091025

| - - Vitablend International Holding B.V. (WOLVEGA)                                       01108879

| - - Vitablend Nederland B.V. (Wolvega)                                                           01108877

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.42

UK Pound

1

Rs.99.17

Euro

1

Rs.72.14

EUR

1

Rs.72.11

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ANK

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.